This invention discloses pharmaceutical use of a dicycloplatin (DCP) for the prophylaxis or treatment of leukemia, renal adenocarcinoma or melanoma. Methods using DCP, either alone or in combination with at least one additional therapeutic agent or adjuvant therapy agent, are also disclosed.